2017
DOI: 10.1016/j.pathol.2017.02.003
|View full text |Cite
|
Sign up to set email alerts
|

Use of the EntericBio Gastro Panel II in a diagnostic microbiology laboratory: challenges and opportunities

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
15
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6

Relationship

0
6

Authors

Journals

citations
Cited by 14 publications
(18 citation statements)
references
References 15 publications
3
15
0
Order By: Relevance
“…As these tests become more prevalent in clinical microbiology laboratories, it is essential that adequate evaluation of molecular tests for the diagnosis of gastrointestinal infections is undertaken. Recent evaluation studies demonstrate that the use of molecular-based diagnostics increases the sensitivity of testing for some enteric pathogens, with overall high negative predictive values [4][5][6][7][8][9][10]. However, the UK National Institute for Health and Care Excellence (NICE) published their diagnostics guidance in January 2017 [11], based on a Diagnostic Assessment Report commissioned by the National Institute of Health Research (NIHR) Health Technology Assessment (HTA) Programme [12].…”
Section: Evidence To Support Molecular-based Diagnostic Testingmentioning
confidence: 99%
See 4 more Smart Citations
“…As these tests become more prevalent in clinical microbiology laboratories, it is essential that adequate evaluation of molecular tests for the diagnosis of gastrointestinal infections is undertaken. Recent evaluation studies demonstrate that the use of molecular-based diagnostics increases the sensitivity of testing for some enteric pathogens, with overall high negative predictive values [4][5][6][7][8][9][10]. However, the UK National Institute for Health and Care Excellence (NICE) published their diagnostics guidance in January 2017 [11], based on a Diagnostic Assessment Report commissioned by the National Institute of Health Research (NIHR) Health Technology Assessment (HTA) Programme [12].…”
Section: Evidence To Support Molecular-based Diagnostic Testingmentioning
confidence: 99%
“…Molecular techniques can detect nucleic acid from organisms at very low levels within samples, leading to an overall increased positivity rate [4][5][6][7][8][9][10]14]. GEMS (Global Enteric Multicentre Study) was a case-control study of diarrhoea in children <five years old in Africa and Asia, published in 2013 [15].…”
Section: Evidence To Support Molecular-based Diagnostic Testingmentioning
confidence: 99%
See 3 more Smart Citations